Compare — Georgia Financials

panel 2026-09-21Ask

Peer percentile within sector

Rank on

Company	Sector	EBITDA margin · FY 2021	Percentile	Sector n
Akhali Khedva	Pharma	35.9%	84th pct	116
SmartPharm	Pharma	9.1%	37th pct	116
Impexpharm	Pharma	7.1%	31st pct	116
Iberi +	Pharma	3.7%	23rd pct	116
Pharmaceutical House+	Pharma	-5.9%	7th pct	116

Percentile is within each company's own sector across the whole FY2021 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.

FY 2021 · GEL thousands · companies ordered by revenueXLSX

Line item	Impexpharm	Pharmaceutical House+	SmartPharm	Iberi +	Akhali Khedva
Total Current Assets	55,427	36,016	10,517	6,695	7,391
Total Non-Current Assets	28,519	2,257	300	1,140	931
TOTAL ASSETS	83,945	38,273	10,817	7,835	8,322
Total Current Liabilities	8,667	31,870	3,568	2,976	1,280
Total Non-Current Liabilities	16,722	9,297	-0	0	2,150
TOTAL LIABILITIES	25,388	41,167	3,568	2,976	3,431
Total Equity	58,557	-2,893	7,249	4,859	4,892
Balance Check (Assets - L&E)	0	0	0	0	0
Total Debt	16,722	12,864	0	0	2,150
Cash & Equivalents	14,283	353	1,962	1,116	1,351
Net Debt	2,438	12,510	-1,962	-1,116	799